News | FFR Technologies | April 25, 2018

HeartFlow FFRct Analysis Added to ITP Payment Program in the U.K.

Designation from NHS England meant to help drive adoption of the technology

 

HeartFlow FFRct Analysis Added to ITP Payment Program in the U.K.

April 25, 2018 — HeartFlow Inc. announced that the National Health Service (NHS) England has chosen the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis as part of the Innovation and Technology Payment (ITP) program. The HeartFlow Analysis was chosen as a new technology to be funded by ITP through a competitive process of nearly 300 applicants. It is the only ITP recipient focused on coronary artery disease (CAD), which affects 2.3 million people in the U.K., according to the British Heart Foundation.

The goal of the ITP is to create the conditions necessary for proven innovations to be adopted faster and more systematically throughout the NHS. Through a competitive process, NHS England identified innovations where financial or procurement barriers were preventing widespread adoption, despite strong evidence that broader adoption would deliver efficiency and improve quality in healthcare. NHS England will provide reimbursement for usage of these technologies through the ITP program to support their adoption throughout the NHS.

The ITP designation for the HeartFlow Analysis follows medical technology guidance issued by the National Institute for Health and Care Excellence (NICE) in February 2017. The guidance recommended the HeartFlow Analysis as the most cost-effective option following a coronary computed tomography angiogram (CTA) when additional information is needed by the clinician for patients with stable chest pain. Additionally, NICE clinical guidelines recommend coronary CTA as the initial diagnostic test for most patients with stable chest pain.

“For patients being assessed in a chest pain clinic with new onset chest pain, the most important focus is to first provide an accurate diagnosis as quickly as possible. It is ideal if we can avoid unnecessary invasive procedures, like angiograms, or prevent having to do multiple tests, one after the other. Most patients don't actually have angina and so being able to reassure patients and avoid unnecessary tests is also really important,” said Andrew Wragg, M.D., consultant cardiologist, Barts Heart Centre. “Using the HeartFlow Analysis at the Barts Heart Centre helps us understand if a patient has a significant narrowing within their heart blood vessels by assessing its impact on the actual blood flow to the heart muscle. This enables us to make a more precise diagnosis and offer the most appropriate treatment. Many patients don’t require any extra tests and can be reassured. Other patients can be correctly identified for more invasive treatments. Also, the time to diagnosis is shorter and combined with avoiding unnecessary tests, this can potentially lead to important cost savings for both the hospital and wider healthcare system.”

Clinicians diagnosing someone with suspected CAD want to know as definitively as possible if the individual has a significant blockage in their coronary arteries. They also want to know the impact of that blockage on blood flow so they can best determine which treatment pathway is appropriate (e.g., medical management, stenting or coronary artery bypass grafting).

Data from a patient’s non-invasive coronary CTA are securely uploaded from the hospital’s system to the cloud. HeartFlow leverages deep learning to create a personalized, digital 3-D model of the patient’s coronary arteries. The HeartFlow Analysis then uses powerful computer algorithms to solve millions of complex equations to simulate blood flow and assess the impact of blockages on coronary blood flow. The HeartFlow FFRct Analysis is provided via a secure online interface to offer actionable information to enable clinicians to determine the optimal course of treatment.

This technology has been demonstrated to reduce unnecessary and invasive diagnostic coronary angiography procedures, which can be associated with bleeding, stroke, major blood vessel damage and other serious complications. It also significantly reduces healthcare costs for hospitals.

For more information: www.heartflow.com

 

Related Content

An example of a cardiac CT scan showing a 3-D reconstriction of the heart showing a stented vessel, and reformatted images showing the stented coronary artery with restenosis from different views. This was imaged using a Canon Aquilion Prime CT system.

An example of a cardiac CT scan showing a 3-D reconstriction of the heart showing a stented vessel, and reformatted images showing the stented coronary artery with restenosis from different views. This was imaged using a Canon Aquilion Prime CT system.

Feature | CT Angiography (CTA) | September 08, 2020
September 8, 2020 — The Journal of the Am
A calcium scoring CT scan showing a segment of heavily calcified coronary artery.

A calcium scoring CT scan showing a segment of heavily calcified coronary artery

News | CT Angiography (CTA) | August 20, 2020
August 20, 2020 – The amount of calcified plaque in the heart’s arteries on...
Sheer stresses on the walls of arteries are believed to cause the formation atherosclerotic plaques. This is an area of research that is expected to see increased use in the next few years. This study was presented at SCCT 2020 as an example of how sheer stresses can help evaluate and predict the patency of coronary artery bypass grafts (CABG). #SCCT2020 #yesCCT

Sheer stresses on the walls of arteries are believed to cause the formation atherosclerotic plaques. This is an area of research that is expected to see increased use in the next few years. This study was presented at SCCT 2020 as an example of how sheer stresses can help evaluate and predict the patency of coronary artery bypass grafts (CABG).

Feature | CT Angiography (CTA) | August 14, 2020 | Dave Fornell, Editor
The latest technical advances and trends in...
During the SCCT 2020 virtual meeting, SCCT President Ron Blackstein, M.D., Brigham and Women's, presents the SCCT Gold Award to John Lesser, M.D., MSCCT, director of advanced imaging and cardiac CT, Minneapolis Heart Institute, Abbott Northwestern Hospital. 

During the SCCT 2020 virtual meeting, SCCT President Ron Blankstein, M.D., Brigham and Women's, presented the SCCT Gold Award to John Lesser, M.D., MSCCT, director of advanced imaging and cardiac CT, Minneapolis Heart Institute, Abbott Northwestern Hospital. 

News | CT Angiography (CTA) | August 14, 2020 | Dave Fornell, Editor
An example of perivascular fat attenuation index (FAI) imaging inside the coronary vascular wall to show areas of inflammation. #SCCT2020

An example of perivascular fat attenuation index (FAI) imaging inside the coronary vascular wall to show areas of inflammation. The technology was created by Oxford University and several experts in cardiac CT imaging say this might be a game changer to improving risk assessments.

Feature | CT Angiography (CTA) | July 30, 2020 | Dave Fornell, Editor
There is a promising recent development in...
A cardiac CT of a patient with pacemaker leads, which can be challenging to get good images due to metal artifact. This image was rendered from using Canon's AiCE AI-assisted interactive reconstruction with Global Illumination 3-D rendering from a scan on an Aquilion One Genesis SP system.

A cardiac CT of a patient with pacemaker leads, which can be challenging to get good images due to metal artifact. This image was rendered from using Canon's AiCE AI-assisted interactive reconstruction with Global Illumination 3-D rendering from a scan on an Aquilion One Genesis SP system.

Feature | CT Angiography (CTA) | July 27, 2020 | Dave Fornell, Editor
There has been tremendous growth in the field of cardiovascular...
The new Aquilion One Genesis SP cardiac CT system uses artificial intelligence to help reconstruct low dose cardiac CT images. #SCCT2020

The new Aquilion One Genesis SP cardiac CT system uses artificial intelligence to help reconstruct low dose cardiac CT images.

News | CT Angiography (CTA) | July 20, 2020
July 20, 2020 – To meet the growing cardiovascular imaging needs of healthcare systems, Canon Medical Systems USA is